Sale!

TORCH Multiplex Detection and Differentiation RNA Detection Qualitative Test Cost

Original price was: 2,600 د.إ.Current price is: 2,210 د.إ.

-15%

The “TORCH Multiplex Detection and Differentiation RNA Detection Qualitative Test” is an advanced diagnostic procedure available at DNA Labs UAE, designed to simultaneously detect and differentiate infections caused by the TORCH complex of viruses. This complex includes Toxoplasma gondii (TOXO), Rubella virus (RUB), Cytomegalovirus (CMV), and Herpes Simplex virus (HSV) 1 and 2. These pathogens are of particular concern in pregnant women, as they can lead to severe congenital infections in the fetus, leading to birth defects or miscarriage.

Utilizing state-of-the-art RNA detection technologies, this qualitative test offers a high degree of sensitivity and specificity, ensuring accurate identification of the viral RNA without the need for multiple tests. This is particularly crucial for early diagnosis and management of infections to mitigate potential risks to both pregnant women and their unborn children.

Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic capabilities and stringent quality control measures, the test assures patients of reliable results. The cost of the test is set at 2210 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed.

This test is an invaluable tool for healthcare providers, offering critical insights into infections by the TORCH viruses, thereby facilitating timely and appropriate interventions to protect maternal and fetal health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TORCH Multiplex Detection and Differentiation RNA Detection Qualitative Test

Welcome to DNA Labs UAE, your trusted genetic lab in the UAE. Today, we will be discussing the TORCH Multiplex Detection and Differentiation RNA Detection Qualitative Test and its cost.

Test Name: TORCH Multiplex Detection and Differentiation RNA Detection Qualitative Test

Components:

  • Price: 2210.0 AED

Sample Condition:

Blood, Serum, Swab, Amniotic fluid, chorionic villus (removal of chorionic villi from the placenta during pregnancy), csf, urine, skin lesions, etc.

Report Delivery:

4th Working Day Email: 48 hours

On phone: 36 hours

Method:

Real Time PCR

Test Type:

Viral

Doctor:

Physician

Test Department:

Genetics

Pre Test Information:

Patients need to sign a Consent document and bring any clinical history for TORCH Multiplex Detection and Differentiation (RNA Detection) Qualitative Test.

Test Details:

The TORCH (Toxoplasma, Other agents, Rubella, Cytomegalovirus, and Herpes simplex virus) Multiplex Detection and Differentiation Test is a qualitative test used to detect and differentiate the presence of RNA from these specific pathogens in a patient’s sample.

The TORCH panel includes various pathogens that can cause congenital infections in newborns if the mother is infected during pregnancy. The test is typically performed on amniotic fluid, fetal blood, or neonatal blood samples.

The test utilizes a multiplex polymerase chain reaction (PCR) technique to simultaneously amplify and detect the RNA of Toxoplasma gondii, Rubella virus, Cytomegalovirus (CMV), and Herpes simplex virus (HSV) in a single reaction. The PCR amplifies specific target sequences from the RNA of these pathogens, allowing for their detection.

The qualitative nature of the test means that it provides a “yes” or “no” answer regarding the presence of RNA from these pathogens in the sample. If the test is positive, it indicates the presence of one or more of these pathogens in the patient’s sample, suggesting a potential infection.

The TORCH Multiplex Detection and Differentiation Test is an important tool in diagnosing congenital infections and guiding appropriate management and treatment for affected infants. It allows for early detection and differentiation of these pathogens, enabling timely intervention to prevent or mitigate the complications associated with these infections.

Test Name TORCH Multiplex detection and Differentiation RNA Detection Qualitative Test
Components
Price 2210.0 AED
Sample Condition Blood, Serum,Swab, Amniotic fluid, chorionic villus (removal of chorionic villi from the placenta during pregnancy), csf, urine, skin lesions.etc
Report Delivery 4th Working Day Email : 48 hours.On phone : 36 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forTORCH Multiplex detection and Differentiation (RNA Detection) QualitativeTest
Test Details

TORCH (Toxoplasma, Other agents, Rubella, Cytomegalovirus, and Herpes simplex virus) multiplex detection and differentiation test is a qualitative test used to detect and differentiate the presence of RNA from these specific pathogens in a patient’s sample.

The TORCH panel includes various pathogens that can cause congenital infections in newborns if the mother is infected during pregnancy. The test is typically performed on amniotic fluid, fetal blood, or neonatal blood samples.

The test utilizes a multiplex polymerase chain reaction (PCR) technique to simultaneously amplify and detect the RNA of Toxoplasma gondii, Rubella virus, Cytomegalovirus (CMV), and Herpes simplex virus (HSV) in a single reaction. The PCR amplifies specific target sequences from the RNA of these pathogens, allowing for their detection.

The qualitative nature of the test means that it provides a “yes” or “no” answer regarding the presence of RNA from these pathogens in the sample. If the test is positive, it indicates the presence of one or more of these pathogens in the patient’s sample, suggesting a potential infection.

The TORCH multiplex detection and differentiation test is an important tool in diagnosing congenital infections and guiding appropriate management and treatment for affected infants. It allows for early detection and differentiation of these pathogens, enabling timely intervention to prevent or mitigate the complications associated with these infections.